Related Experiment Video
Updated: Jul 20, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Idiopathic pulmonary fibrosis: an update
O J Dempsey1, K M Kerr, L Gomersall
1Department of Respiratory Medicine, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN. owen.dempsey@nhs.net
QJM : Monthly Journal of the Association of Physicians
|September 8, 2006
Summary
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease with limited treatment options. Further research into its causes and new therapies is crucial due to poor prognosis.
Area of Science:
- Pulmonology
- Pathology
- Radiology
Background:
- Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible lung disease with unknown causes.
- It presents with symptoms like breathlessness, cough, and reduced exercise tolerance.
- Diagnosis involves characteristic histopathology (usual interstitial pneumonia) and radiological findings.
Purpose of the Study:
- To highlight the diagnostic considerations for IPF.
- To underscore the limited management options and poor prognosis.
- To emphasize the urgent need for research into IPF pathogenesis and novel treatments.
Main Methods:
- Differential diagnosis considerations for patients with relevant symptoms.
- Histopathological confirmation of usual interstitial pneumonia.
- Radiological assessment for typical IPF appearances.
Main Results:
- IPF necessitates consideration in patients with unexplained respiratory symptoms.
- Current management is largely palliative, with lung transplantation as an option for a few.
- Median survival is approximately 3 years, indicating a critical unmet need.
Conclusions:
- IPF is a serious condition requiring early consideration in clinical practice.
- Effective disease-modifying therapies are lacking.
- Further investigation into IPF pathogenesis and pharmacological treatments is essential.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...